Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Moderate-to-severe Chronic Plaque Psoriasis
View Full LandscapeTarget Indication
Moderate-to-severe Chronic Plaque Psoriasis
Clinical Trial
NCT07362017Last updated: 6/11/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Ponvory
Ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features.
View on EMA